Quadrisol oral gel for horses 3x30 ml NL-DE-FR
Active ingredient: Vedaprofen 100 mg/ml
Target species: Horse
Quadrisol is a powerful antipyretic NSAID. The temperature of the horse stays under control as long as treatment lasts.
As a painkiller Quadrisol is found to be less effective than other NSAIDs. This may be preferred when a lower threshold is desired, enabling to be alarmed as soon as the ailment worsens, e.g. in case of (light) colic and certain cases of lameness.
Reduction of inflammation and relief of pain associated with musculo-skeletal disorders and soft tissue lesions (traumatic injuries and surgical trauma). In cases of anticipated surgical trauma, Quadrisol can be given prophylactically at least 3 hours prior to elective surgery.
- Quadrisol is approved for use during gestation.
- Foals can be treated with Quadrisol from 6 months of age onwards.
- In cases of anticipated surgical trauma, Quadrisol can be given prophylactically at least 3 hours prior to surgery.
- Detection time of Quadrisol is maximally 6 days in urine and 2 days in blood.
Contra-indications Do not use Quadrisol in animals suffering from alimentary tract disorders, impaired heart, liver and kidney function. Do not use in foals under the age of 6 months. Do not use in lactating mares. Do not use in the case of hypersensitivity to the active substance or to any of the excipients.
Withdrawal period Meat and offal: 12 days. Quadrisol is not authorised for use in lactating animals producing milk for human consumption.
- Additional Information
SKU 120408 Tax Class 9% Brand Grovet Route of Administration Oral Active Ingredient Vedaprofen Withdrawal period 12 days Target Species Equine Registrationnumber REG NL 9800
Instructions for use
Route of administration and dosage
Single starting dosage: 2 mg / kg > 2 ml per 100 kg
Maintenance dosage: 1 mg / kg > 1 ml per 100 kg (twice a day)
Starting dose for a 500 kg horse is 10 ml, the maintenance dose for this example is 5 ml twice a day.
For oral use.
Twice daily administration of Quadrisol. An initial dose of 2 mg/kg (2.0 ml/100 kg) is followed by a maintenance dose of 1 mg/kg (1.0 ml/100 kg) given every 12 hours. Treatment can be continued for a maximum of 14 consecutive days.
In case of prophylactic treatment, a maximum duration of treatment of 7 consecutive days is sufficient. Bodyweight and dosage must be accurately determined to avoid overdosing. The gel is administered orally by inserting the nozzle of the syringe through the interdental space and depositing the required amount of gel on the back of the tongue.
Before administration of the Quadrisol, the syringe should be adjusted to the calculated dosage by setting the ring on the plunger. It is advisable to administer the product before feeding.